A phase II study of 5-fluorouracil, cisplatin, and 4'-epirubicin in the treatment of advanced solid cancers.

Y Nio; C C Tseng; T Shiraishi; M Tsubono; K Kawabata; Y Masai; H Hayashi; M Fukumoto; M Nio; M Sato

doi:10.1097/00000421-199304000-00002

A phase II study of 5-fluorouracil, cisplatin, and 4'-epirubicin in the treatment of advanced solid cancers.

NobleID: NI7P75W05R75S61
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/088ACE1C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/088ACE1C.svg?ark=w1%2F20260515%2F088ACE1C&value=id)](https://nobleid.org/work/w1/20260515/088ACE1C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II study of 5-fluorouracil, cisplatin, and 4'-epirubicin in the treatment of advanced solid cancers.

NobleID: NI7P75W05R75S61
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/088ACE1C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/088ACE1C.svg?ark=w1%2F20260515%2F088ACE1C&value=id)](https://nobleid.org/work/w1/20260515/088ACE1C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work